Altimmune closed a $75M direct offering to fund Phase 3 pemvidutide trials for MASH, leveraging recent positive Phase 2b data and FDA Breakthrough Therapy status. Pemvidutide’s dual GLP-1/glucagon ...

The biggest stories of the day delivered to your inbox.

Forbes contributors publish independent expert analyses and insights. John Hall covers entrepreneurial topics that help companies grow. For as long as there has been an exchange of goods and services ...

Add Yahoo as a preferred source to see more of our stories on Google. What might hold you back from standing up for a colleague who's treated unfairly? AnVr/E+ via Getty Images What really holds ...

Iranian Foreign Minister Abbas Araghchi said Tehran is "completely serious" about the negotiations with the Trump administration as it seeks to avoid airstrikes, but blamed the U.S. for a "very large ...

Forbes contributors publish independent expert analyses and insights. I cover the intersection of culture and media. I’m standing in front of a seminar of college seniors flabbergasted. It’s not that ...

Patients with advanced lung cancer had better survival outcomes when they received immunochemotherapy earlier in the day, a randomized trial showed. Morning circulating CD8+ T cells increased in the ...

Total crypto market capitalization has fallen by about $467.6B since Jan. 29 as a selloff led by Bitcoin (BTC-USD) gathered pace, Bloomberg reported, citing data from CoinGecko. Bitcoin (BTC-USD) slid ...